Major players in the ENT surgical devices and equipment market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd, KLS Martin LP, Acclarent Inc, Medtronic, Smith & Nephew, Boston Scientific, Olympus, and ClaroNav.

New York, May 13, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "ENT Surgical Devices And Equipment Global Market Report 2022" - https://www.reportlinker.com/p06277227/?utm_source=GNW The global ent surgical devices and equipment market is expected to grow from $4.69 billion in 2021 to $5.25 billion in 2022 at a compound annual growth rate (CAGR) of 11.9%. The market is expected to grow to $7.95 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The ENT surgical devices and equipment market consists of sales of ENT (ear-nose-throat) surgical devices. ENT surgical devices include balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes, and handheld instruments are used to perform surgical procedures such as tonsillectomy, tracheostomy, implantations, septorhinoplasty, turbinate reduction, mastoidectomy, stapedectomy, and reconstruction surgeries. The main products in ENT surgical devices and equipment are hand instruments, ENT surgical lasers, powered ENT surgical systems, radiofrequency electrosurgical devices, ENT surgery workstations, ENT surgical navigation system, ENT visualization system, and surgical microscopes.These devices and equipment are hand-held devices, portable devices, and fixed devices. The various end-users are hospitals, ambulatory surgical centers, and ENT clinics. Asia Pacific was the largest region in the ENT surgical devices and equipment market in 2021.North America was the second-largest region in the ENT surgical devices and equipment market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future.For example, minimally invasive ENT surgeries offer patients many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In the majority of the cases, physicians enjoy a higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market. Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market.ENT surgical procedures are complex, involve greater devices, and thus are relatively expensive. The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market. ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries.It involves less tissue damage, reduced scarring, and faster recovery thereby leading to greater adoption and would see an increase in the market potential. Robot-assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with the ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted. The ENT surgical devices and equipment industry has lately witnessed a rise in the number of FDA clearances which would positively impact the market growth.A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by the FDA, the FDA 510(K) is expected to see several updates to regulate safety, technology, and capabilities in the medical devices space.The European Union’s Medical Device Regulation (MDR) presented a few changes that would come into force by 2020. The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management. In 2020, Intersect ENT, a USA-based ear, nose, and throat condition treatment developer, announced to acquire Fiagon for USD 71.1 million. The acquisition was aimed to help Intersect ENT to expand its product portfolio and to extend its geographical reach. Fiagon develops surgical navigation systems that support both routine and complex ENT procedures and is based in Germany. The countries covered in ENT surgical devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. Read the full report: https://www.reportlinker.com/p06277227/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

Trading halted on GameStop multiple times as it soars 30%

ZURICH (Reuters) -Siemens will quit the Russian market due to the war in Ukraine, it said on Thursday, taking a 600 million euro ($630 million) hit to its business during the second quarter, with more costs to come. The German industrial and technology group became the latest multinational to announce losses linked to its decision to leave Russia following the Feb. 24 invasion, which Moscow calls a "special military operation". Several companies, from brewers Anheuser-Busch InBev and Carlsberg to sportswear maker Adidas, carmaker Renault and several banks have been counting the cost of suspending operations in or withdrawing from Russia.

Shares of Kelly Services Inc. were indicated up more than 3% in premarket trading Thursday, after the staffing services company beat profit and revenue expectations and boosted its dividend by 50%. The company swung to a net loss of $47.6 million, or $1.23 a share, from income of $25.6 million, or 64 cents a share, in the year-ago period. Excluding nonrecurring items, such as a losses on its Persol Holdings investment and on foreign currency matters, adjusted earnings per share of 46 cents beat

Raising interest rates might kill the housing market and choke off price increases temporarily, but it won't solve the problem of an inadequate supply of homes.

Keeping workers satisfied is tough these days, so some companies are putting executives in charge of employees’ happiness.

(Bloomberg) -- Masayoshi Son is paying a steep price for his outsized wagers on money-losing technology companies. Most Read from BloombergElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverSony PlayStation Staff Fume Over CEO’s Abortion CommentsApple Testing iPhones That Ditch Lightning Ports in Favor of USB-CUkraine Latest: US Senator Delays Aid Vote; Russia Eyes BorderStocks Roar Back at End of Nerve-Racking Week: Markets WrapSon’s SoftBank Group Corp. reported a record annual loss at

The US Patent Trial and Appeal Board (PTAB) issued a final written decision in favor of Concert Pharmaceuticals Inc (NASDAQ: CNCE) regarding the post-grant review (PGR) for the '659 method-of-use patent. The '659 patent claims methods of treating hair loss, including alopecia areata with certain doses of CTP-543, a deuterated form of ruxolitinib, JAK 1/2 inhibitor, being marketed by Incyte Corporation (NASDAQ: INCY). The patent expires in 2037. PTAB upholds all of the challenged claims of the '6

The S&P 500, which is dominated by mega-cap stocks, has dropped 17% this year. But there may be opportunities.

Compass Diversified Holdings CEO Elias Sabo says inflation is affecting sales among less affluent shoppers. Luxury products haven't been impacted.

The company hired a financial adviser last October to explore the sale of its process technology division.

The direction of the USD/JPY on Friday is likely to be determined by trader reaction to 129.147.

Veteran market technician Andrew Addison says there is no evidence that more stocks are reversing their downtrends as the broad indexes fall.

The bank holding company's stock ended its first day of trading at less than the offering price because of an aberrant trade.

(Bloomberg) -- The market for a key component in the production of gasoline is about to get tighter in Europe -- bad news for motorists already contending with soaring prices for the fuel.Most Read from BloombergSony PlayStation Staff Fume Over CEO’s Abortion CommentsElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverUkraine Latest: US Senator Delays Aid Vote; Russia Eyes BorderTerraform Again Halts Blockchain Behind UST Stablecoin, LunaMore Than $200 Billion Wiped Off Cryptocurrency Mark

(Bloomberg) -- Hedge funds have made a profit of about $1.25 billion on paper by betting against the shares of Danish medical equipment company Ambu A/S over the past year.Most Read from BloombergCrypto Billionaires’ Vast Fortunes Are Destroyed in WeeksNike Escalates StockX Feud, Says Site Is Selling Fake ShoesUkraine Latest: Germany Can Withstand Gas Halt; US Eyes DronesKim Orders Lockdown After North Korea Reports First Covid CaseDon’t Bother Paying Off Student Loan Debt Right Now, Advisers Sa

U.S. stocks ended a whipsaw session slightly lower on Thursday, as investors juggled signs of peaking inflation with fears that it could remain elevated, prompting ever more aggressive tightening from the Federal Reserve. All three major U.S. stock indexes seesawed and the S&P 500 came within striking distance of confirming it entered a bear market after swooning from its all-time high reached on Jan. 3.

Stablecoins are cryptocurrencies designed to minimize price volatility, making them more useful as a store of value and a medium of exchange.

Didi Global, the Chinese ride-hailing giant whose New York listing triggered cybersecurity investigations by Beijing last summer, urged shareholders to vote at a meeting later this month to delist from the New York Stock Exchange, saying it is necessary to satisfy Chinese authorities. Didi said it "has concluded that it needs to complete the cybersecurity review and rectification in order to resume normal operations", including restoring its 26 apps in Chinese app stores so that the company can

(Bloomberg) -- A fresh bout of risk aversion spreading through markets is rekindling investor appetite in what investors have long considered some of the world’s safest assets.Most Read from BloombergCrypto Billionaires’ Vast Fortunes Are Destroyed in WeeksMore Than $200 Billion Wiped Off Cryptocurrency Market in a DayNike Escalates StockX Feud, Says Site Is Selling Fake ShoesUS Stocks Almost Wipe Out Losses Into the Close: Markets WrapUkraine Latest: Germany Can Withstand Gas Halt; US Eyes Dron

Here's another cold, hard truth that many proponents of penny stocks don't tell you: Many low-priced shares stay low for a very long time.